BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16139445)

  • 1. Identification of risk factors for prevention and early diagnosis of a-symptomatic post-menopausal women.
    Ferrer J; Neyro JL; Estevez A
    Maturitas; 2005 Nov; 52 Suppl 1():S7-22. PubMed ID: 16139445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
    Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
    J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of the most frequent diseases in the European a-symptomatic post-menopausal women. Is there any difference between Ireland and the rest of Europe?
    Fogarty P; O'Beirne B; Casey C
    Maturitas; 2005 Nov; 52 Suppl 1():S3-6. PubMed ID: 16139448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.
    Col NF; Chlebowski RT
    Menopause; 2008; 15(4 Suppl):804-9. PubMed ID: 18596602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health hazards in middle-aged women with cardiovascular disease: a case-control study of swedish women. the women's health in the Lund area (WHILA) study.
    Shakir YA; Samsioe G; Khatibi E A; Nyberg P; Lidfeldt J; Agardh CD; Nerbrand C
    J Womens Health (Larchmt); 2007 Apr; 16(3):406-14. PubMed ID: 17439385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease: screening and management of the a-symptomatic high-risk post-menopausal woman.
    Creatsas G; Christodoulakos G; Lambrinoudaki I
    Maturitas; 2005 Nov; 52 Suppl 1():S32-7. PubMed ID: 16140482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHI risks: any relevance to menopause management?
    Burger HG
    Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing cardiovascular disease in women.
    Hayes SN
    Am Fam Physician; 2006 Oct; 74(8):1331-40. PubMed ID: 17087427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, etiology, and diagnosis of osteoporosis.
    Lane NE
    Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S3-11. PubMed ID: 16448873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of preventive health care in post-menopausal women.
    Palacios S; Borrego RS; Forteza A
    Maturitas; 2005 Nov; 52 Suppl 1():S53-60. PubMed ID: 16129574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.
    Vogel VG
    Menopause; 2008; 15(4 Suppl):782-9. PubMed ID: 18596599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women.
    Lukaczer D; Liska DJ; Lerman RH; Darland G; Schiltz B; Tripp M; Bland JS
    Nutrition; 2006 Feb; 22(2):104-13. PubMed ID: 16459222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to identify individuals with elevated cardiovascular risk?].
    Klemsdal TO; Tonstad S; Hjermann I
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):799-801. PubMed ID: 15039814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individuals' cardiovascular risk profile projected by family doctors and individuals' knowledge of cardiovascular risk factors: a challenge for primary prevention. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Celentano A; Palmieri V; Panico S; Russo C; Arezzi E; Pezzullo S; Minichiello S; Guillaro B; Brancati C; Piccinocchi G; Di Minno G
    Ital Heart J; 2005 Jul; 6(7):557-64. PubMed ID: 16274017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.